FITC Anti-Human CD27 Antibody [O323] (AGEL1706)

FITC Anti-Human CD27 Antibody [O323]

The Human CD27 Monoclonal Antibody (FITC Conjugated) (O323-AGEL1706) from AssayGenie is a powerful tool for researchers studying the CD27 protein, a key molecule involved in immune responses and signaling pathways. This antibody, specifically designed for use with human samples, is conjugated with FITC for easy detection and visualization in flow cytometry and immunofluorescence experiments.CD27, a member of the tumor necrosis factor receptor superfamily, plays a crucial role in the activation and differentiation of T and B cells, making it an important target in immunology research. By binding to the CD27 protein, this monoclonal antibody allows for precise detection and analysis of CD27 expression in various cell types, providing valuable insights into immune function and cell signaling mechanisms.

With its high specificity and sensitivity, the Human CD27 Monoclonal Antibody (FITC Conjugated) is a valuable tool for investigating the role of CD27 in immune responses, autoimmune diseases, and cancer biology. Researchers can leverage this antibody to further understand the functions and interactions of CD27, paving the way for the development of novel therapeutic strategies targeting this critical immune regulator.Enhance your research with the Human CD27 Monoclonal Antibody (FITC Conjugated) from AssayGenie and unlock new possibilities in immunology, oncology, and beyond.

Isotype:	Mouse IgG1, κ
Isotype Control:	FITC Mouse IgG1, κ Isotype Control[MOPC-21]
Form:	Liquid
Conjugation:	FITC
Recommended Use:	Each lot of this antibody is quality control tested by flow cytometric analysis. The amount of the reagent is suggested to be used 5 µL of antibody per test (million cells in 100 µL staining volume or per 100 µL of whole blood). Please check your vial before the experiment. Since applications vary, the appropriate dilutions must be determined for individual use.
Spectrum: